Infographic: Everest II study “Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment”

被引：0
|
作者：
Chinmayi Himanshuroy Vyas
Pooi Wah Lott
Rubamalar Gunatheesan
Shaun Sebastian Sim
Christopher Ziyu Sun
Kelvin Yi Chong Teo
Chui Ming Gemmy Cheung
机构：
[1] Singapore National Eye Centre,Singapore Eye Research Institute
[2] National University of Singapore,Duke
来源：
Eye | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1140 / 1141
页数：1
相关论文
共 50 条
  • [1] Infographic: Everest II study "Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment"
    Vyas, Chinmayi Himanshuroy
    Lott, Pooi Wah
    Gunatheesan, Rubamalar
    Sim, Shaun Sebastian
    Sun, Christopher Ziyu
    Teo, Kelvin Yi Chong
    Cheung, Chui Ming Gemmy
    EYE, 2022, 36 (06) : 1140 - 1141
  • [2] Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)”
    Shaun Sebastian Sim
    Chinmayi Himanshuroy Vyas
    Rubamalar Gunatheesan
    Pooi Wah Lott
    Christopher Ziyu Sun
    Kelvin Yi Chong Teo
    Chui Ming Gemmy Cheung
    Eye, 2022, 36 : 1142 - 1142
  • [3] Infographic: "Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)"
    Sim, Shaun Sebastian
    Vyas, Chinmayi Himanshuroy
    Gunatheesan, Rubamalar
    Lott, Pooi Wah
    Sun, Christopher Ziyu
    Teo, Kelvin Yi Chong
    Cheung, Chui Ming Gemmy
    EYE, 2022, 36 (06) : 1142 - 1142
  • [4] Verteporfin PDT and Ranibizumab Combination Therapy for Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV): EVEREST Results
    Lai, T. Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [5] Baseline characteristics of polypoidal choroidal vasculopathy in the EVEREST II Study
    Lim, Tock H.
    Feller, Chrystel
    Margaron, Philippe
    Tan, Colin S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
    Tan, Colin S. H.
    Lim, Louis W.
    Ngo, Wei Kiong
    Cheong, Kai Xiong
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (11) : 684 - 684
  • [7] Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study
    Kelvin Yi Chong Teo
    Kyu-Hyung Park
    Nor Fariza Ngah
    Shih-Jen Chen
    Paisan Ruamviboonsuk
    Ryusaburo Mori
    Nagako Kondo
    Won Ki Lee
    Rajesh Rajagopalan
    Ryo Obata
    Ian Y. H. Wong
    Caroline Chee
    Hiroko Terasaki
    Tetsuju Sekiryu
    Shih-Chou Chen
    Yasuo Yanagi
    Shigeru Honda
    Timothy Y. Y. Lai
    Chui Ming Gemmy Cheung
    Ophthalmology and Therapy, 2024, 13 : 935 - 954
  • [8] EVEREST STUDY Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy
    Koh, Adrian
    Lee, Won Ki
    Chen, Lee-Jen
    Chen, Shih-Jen
    Hashad, Yehia
    Kim, Hakyoung
    Lai, Timothy Y.
    Pilz, Stefan
    Ruamviboonsuk, Paisan
    Tokaji, Erika
    Weisberger, Annemarie
    Lim, Tock H.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1453 - 1464
  • [9] Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study
    Teo, Kelvin Yi Chong
    Park, Kyu-Hyung
    Ngah, Nor Fariza
    Chen, Shih-Jen
    Ruamviboonsuk, Paisan
    Mori, Ryusaburo
    Kondo, Nagako
    Lee, Won Ki
    Rajagopalan, Rajesh
    Obata, Ryo
    Wong, Ian Y. H.
    Chee, Caroline
    Terasaki, Hiroko
    Sekiryu, Tetsuju
    Chen, Shih-Chou
    Yanagi, Yasuo
    Honda, Shigeru
    Lai, Timothy Y. Y.
    Cheung, Chui Ming Gemmy
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (04) : 935 - 954
  • [10] Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
    Takahashi, Kanji
    Ohji, Masahito
    Terasaki, Hiroko
    Honda, Shigeru
    Margaron, Philippe
    Guerin, Tadhg
    Yuzawa, Mitsuko
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1789 - 1799
12345